BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 36307554)

  • 1. Can quantitative peritumoral CT radiomics features predict the prognosis of patients with non-small cell lung cancer? A systematic review.
    Wu L; Lou X; Kong N; Xu M; Gao C
    Eur Radiol; 2023 Mar; 33(3):2105-2117. PubMed ID: 36307554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CT radiomics-based model for predicting TMB and immunotherapy response in non-small cell lung cancer.
    Wang J; Wang J; Huang X; Zhou Y; Qi J; Sun X; Nie J; Hu Z; Wang S; Hong B; Wang H
    BMC Med Imaging; 2024 Feb; 24(1):45. PubMed ID: 38360550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT-based radiomics for differentiating invasive adenocarcinomas from indolent lung adenocarcinomas appearing as ground-glass nodules: Asystematic review.
    Shi L; Zhao J; Peng X; Wang Y; Liu L; Sheng M
    Eur J Radiol; 2021 Nov; 144():109956. PubMed ID: 34563797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review, Meta-Analysis and Radiomics Quality Score Assessment of CT Radiomics-Based Models Predicting Tumor EGFR Mutation Status in Patients with Non-Small-Cell Lung Cancer.
    Felfli M; Liu Y; Zerka F; Voyton C; Thinnes A; Jacques S; Iannessi A; Bodard S
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning-based radiomics strategy for prediction of cell proliferation in non-small cell lung cancer.
    Gu Q; Feng Z; Liang Q; Li M; Deng J; Ma M; Wang W; Liu J; Liu P; Rong P
    Eur J Radiol; 2019 Sep; 118():32-37. PubMed ID: 31439255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral and peritumoral CT-based radiomics strategy reveals distinct subtypes of non-small-cell lung cancer.
    Tang X; Huang H; Du P; Wang L; Yin H; Xu X
    J Cancer Res Clin Oncol; 2022 Sep; 148(9):2247-2260. PubMed ID: 35430688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integrated model combined intra- and peritumoral regions for predicting chemoradiation response of non small cell lung cancers based on radiomics and deep learning.
    Ma Y; Li Q
    Cancer Radiother; 2023 Dec; 27(8):705-711. PubMed ID: 37932182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of intratumoral and peritumoral CT radiomics for the prediction of EGFR gene mutation in primary lung cancer.
    Yamazaki M; Yagi T; Tominaga M; Minato K; Ishikawa H
    Br J Radiol; 2022 Dec; 95(1140):20220374. PubMed ID: 36115683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of computed tomography imaging-based radiomics and clinicopathological characteristics for predicting the clinical benefits of immune checkpoint inhibitors in lung cancer.
    Yang B; Zhou L; Zhong J; Lv T; Li A; Ma L; Zhong J; Yin S; Huang L; Zhou C; Li X; Ge YQ; Tao X; Zhang L; Son Y; Lu G
    Respir Res; 2021 Jun; 22(1):189. PubMed ID: 34183009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC.
    Dou TH; Coroller TP; van Griethuysen JJM; Mak RH; Aerts HJWL
    PLoS One; 2018; 13(11):e0206108. PubMed ID: 30388114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current progress and quality of radiomic studies for predicting EGFR mutation in patients with non-small cell lung cancer using PET/CT images: a systematic review.
    Abdurixiti M; Nijiati M; Shen R; Ya Q; Abuduxiku N; Nijiati M
    Br J Radiol; 2021 Jun; 94(1122):20201272. PubMed ID: 33882244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing brain metastasis prediction in non-small cell lung cancer: a deep learning-based segmentation and CT radiomics-based ensemble learning model.
    Gong J; Wang T; Wang Z; Chu X; Hu T; Li M; Peng W; Feng F; Tong T; Gu Y
    Cancer Imaging; 2024 Jan; 24(1):1. PubMed ID: 38167564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT-based intratumoral and peritumoral deep transfer learning features prediction of lymph node metastasis in non-small cell lung cancer.
    Lu T; Ma J; Zou J; Jiang C; Li Y; Han J
    J Xray Sci Technol; 2024; 32(3):597-609. PubMed ID: 38578874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of early stage non-small cell lung cancers on computed tomographic images into histological types using radiomic features: interobserver delineation variability analysis.
    Haga A; Takahashi W; Aoki S; Nawa K; Yamashita H; Abe O; Nakagawa K
    Radiol Phys Technol; 2018 Mar; 11(1):27-35. PubMed ID: 29209915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cone-beam CT radiomics features might improve the prediction of lung toxicity after SBRT in stage I NSCLC patients.
    Qin Q; Shi A; Zhang R; Wen Q; Niu T; Chen J; Qiu Q; Wan Y; Sun X; Xing L
    Thorac Cancer; 2020 Apr; 11(4):964-972. PubMed ID: 32061061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
    Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
    Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could the underlying biological basis of prognostic radiomics and deep learning signatures be explored in patients with lung cancer? A systematic review.
    Qian L; Wu T; Kong S; Lou X; Jiang Y; Tan Z; Wu L; Gao C
    Eur J Radiol; 2024 Feb; 171():111314. PubMed ID: 38244306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT Radiomics Signature of Tumor and Peritumoral Lung Parenchyma to Predict Nonsmall Cell Lung Cancer Postsurgical Recurrence Risk.
    Akinci D'Antonoli T; Farchione A; Lenkowicz J; Chiappetta M; Cicchetti G; Martino A; Ottavianelli A; Manfredi R; Margaritora S; Bonomo L; Valentini V; Larici AR
    Acad Radiol; 2020 Apr; 27(4):497-507. PubMed ID: 31285150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Non-Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics.
    Dercle L; Fronheiser M; Lu L; Du S; Hayes W; Leung DK; Roy A; Wilkerson J; Guo P; Fojo AT; Schwartz LH; Zhao B
    Clin Cancer Res; 2020 May; 26(9):2151-2162. PubMed ID: 32198149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomics in predicting treatment response in non-small-cell lung cancer: current status, challenges and future perspectives.
    Chetan MR; Gleeson FV
    Eur Radiol; 2021 Feb; 31(2):1049-1058. PubMed ID: 32809167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.